HLS Therapeutics to Host Annual Shareholder Meeting

HLS Therapeutics to Host Annual Shareholder Meeting

Canada NewsWire

TORONTO, June 15, 2018 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") HLS announces details of its upcoming Annual Meeting of Shareholders.

Date:

Friday June 22, 2018





Time:

10:00 a.m. ET





Location:

Blake, Cassels & Graydon LLP

199 Bay Street

Commerce Court West, Suite 4000

Toronto, Ontario M5L 1A9

About HLS Therapeutics Inc.

HLS HLS is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established, branded pharmaceutical products in the North American markets. HLS's focus is on products targeting the central nervous system and cardiovascular therapeutic areas. HLS's management team is comprised of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE HLS Therapeutics Inc.

View original content: http://www.newswire.ca/en/releases/archive/June2018/15/c8322.html

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!